The test does not predict exact medication response but rather provides context to guide clinical discussion and monitoring expectations
In a 2023 study, researchers said that GLP-1 drugs anti-inflammatory properties may help reduce cancer risks
Despite their importance, GLP-1RAs were, until recently, only available for subcutaneous administration, which may have contributed to lower usage rates versus orally available therapies (i.e., SGLT2is and DPP-4 inhibitors) [6, 7, 34,35,36,37]
For comprehensive strategies on preventing weight regain after stopping treatment, see our complete retatrutide maintenance and weight regain guide
Complete FDA-approved schedule The escalation follows a strict protocol designed to minimize gastrointestinal side effects while building toward therapeutic doses
Looking to stock up